iBio, Inc. (IBIO): Price and Financial Metrics

iBio, Inc. (IBIO): $4.06

0.70 (+20.83%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

D

Add IBIO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#242 of 367

in industry

IBIO Price/Volume Stats

Current price $4.06 52-week high $49.00
Prev. close $3.36 52-week low $1.02
Day low $3.66 Volume 50,664,500
Day high $4.98 Avg. volume 3,723,533
50-day MA $1.26 Dividend yield N/A
200-day MA $5.34 Market Cap 14.15M

IBIO Stock Price Chart Interactive Chart >


iBio, Inc. (IBIO) Company Bio


iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.


IBIO Latest News Stream


Event/Time News Detail
Loading, please wait...

IBIO Latest Social Stream


Loading social stream, please wait...

View Full IBIO Social Stream

Latest IBIO News From Around the Web

Below are the latest news stories about IBIO INC that investors may wish to consider to help them evaluate IBIO as an investment opportunity.

iBio Amends and Extends Maturity of Credit Agreement

– Extends maturity date to March 29, 2024 – – Allows for more time to complete planned divestiture of legacy CDMO business - BRYAN, Texas and SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, today announced its wholly owned subsidiary, iBio CDMO LLC, and its lender, Woodforest National Bank (“Woodforest”), have entered into an amendment (the “Amendment”) to the Credit Agreement dated Nove

Yahoo | December 26, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest trading news for Tuesday morning!

William White on InvestorPlace | December 5, 2023

Piper Sandler Is Souring on Albemarle (ALB) Stock

Albemarle stock is falling on Tuesday alongside a downgrade and price target reduction for ALB shares from a Piper Sandler analyst.

William White on InvestorPlace | December 5, 2023

Why Is iBio (IBIO) Stock Down 41% Today?

Ibio stock is falling on Tuesday after the biotechnology company announced the pricing of its shares in a public offering.

William White on InvestorPlace | December 5, 2023

Why Is SilverSun Technologies (SSNT) Stock Down 28% Today?

SilverSun Technologies stock is falling on Tuesday but that's only due to shares of SSNT giving up ground that was gained on Monday.

William White on InvestorPlace | December 5, 2023

Read More 'IBIO' Stories Here

IBIO Price Returns

1-mo 235.54%
3-mo 196.35%
6-mo -33.11%
1-year -90.33%
3-year -99.46%
5-year -99.07%
YTD 196.35%
2023 -84.59%
2022 -96.76%
2021 -47.71%
2020 321.69%
2019 -66.80%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!